Abstract
James McCormack and Michael Allan discuss issues and questions surrounding hsCRP measurements in patients.
MeSH terms
-
Aged
-
Biomarkers / blood
-
C-Reactive Protein / analysis*
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / immunology
-
Cardiovascular Diseases / prevention & control
-
Evidence-Based Medicine
-
Female
-
Fluorobenzenes / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Male
-
Predictive Value of Tests
-
Pyrimidines / therapeutic use
-
Randomized Controlled Trials as Topic
-
Reproducibility of Results
-
Risk Assessment
-
Rosuvastatin Calcium
-
Sulfonamides / therapeutic use
-
Treatment Outcome
-
Unnecessary Procedures*
Substances
-
Biomarkers
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrimidines
-
Sulfonamides
-
Rosuvastatin Calcium
-
C-Reactive Protein